Seeing Is Believing
AKRO is currently covered by 4 analysts with an average price target of $67. This is a potential upside of $23.21 (22.6%) from yesterday's end of day stock price of $54.65.
Akero Therapeutics's activity chart (see below) currently has 89 price targets and 79 ratings on display. The stock rating distribution of AKRO is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 39.54% with an average time for these price targets to be met of 204.46 days.
Highest price target for AKRO is $84, Lowest price target is $54, average price target is $67.
Most recent stock forecast was given by PRAKHAR AGRAWAL from CANTOR FITZGERALD on 10-Dec-2025. First documented stock forecast 15-Jul-2019.
Currently out of the existing stock ratings of AKRO, 5 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 19-Sep-2023
7 months 2 days ago
(10-Dec-2025)
0/4 (0%)
$29.93 (96.33%)
Buy Since 04-Sep-2025
$54
$-0.65 (-1.19%)
$72
9 months 2 days ago
(10-Oct-2025)
2/7 (28.57%)
$0.12 (0.22%)
70
Buy Since 10-Feb-2020
$54
$-0.65 (-1.19%)
$56
9 months 3 days ago
(09-Oct-2025)
7/10 (70%)
$-0.08 (-0.15%)
356
Buy Since 19-Dec-2022
$84
$29.35 (53.71%)
$84
11 months 6 days ago
(06-Aug-2025)
1/7 (14.29%)
$31.21 (59.12%)
329
Buy Since 04-Aug-2025
$76
$21.35 (39.07%)
11 months 8 days ago
(04-Aug-2025)
0/1 (0%)
$27.38 (56.31%)
What is AKRO (Akero Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on AKRO (Akero Therapeutics) with a proven track record?
Which analyst has the most public recommendations on AKRO (Akero Therapeutics)?
Which analyst is the currently most bullish on AKRO (Akero Therapeutics)?
Which analyst is the currently most reserved on AKRO (Akero Therapeutics)?